Simultaneous assessment of cerebral glucose consumption
rate (CMR
glc
) and TCA cycling rate (V
TCA
)
is crucial for understanding neuroenergetics under
various physiopathological conditions; nevertheless,
such measurement was not possible. Recently, we
developed a novel
in
vivo
Deuterium
(
2
H) MR (DMR) approach for noninvasively
assessing glucose metabolisms in rat brain at 16.4 T.
Following a brief injection of deuterated glucose, the
dynamic labeling on glucose, glutamate/glutamine (Glx),
water and lactate in the brain tissue can be monitored
via tracking their well-resolved
2
H
signals. To quantify metabolic rates, a new kinetic
model incorporating glycolysis, TCA cycle and
-ketoglutarate/Glx
exchange was developed in this study. By least-square
fitting of the model with the experimental data obtained
from dynamic DMR measurement in rat brains, major
metabolic fluxes such as CMR
glc
and
V
TCA
can
be determined concurrently. Two different metabolic
conditions were examined; increased CMR
glc
(0.46
vs. 0.28 mol/g/min) and V
TCA
(0.96
vs. 0.6 mol/g/min) were found under morphine infusion
as compare to the deeper anesthesia of 2% isoflurane,
which are consistent with previous
in
vivo
13
C
or
1
H
MRS studies. In summary, we demonstrate that the new DMR
approach in combine with the kinetic model described in
this work is capable of simultaneously determining CMR
glc
and
V
TCA
with
high sensitivity and reliability.